Australian Clinical Labs Limited (ACL.AX)
AUD 3.49
(-3.32%)
AUD 3.49
(-3.32%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 308.89 Million AUD | -2.35% |
| 2023 | 316.31 Million AUD | 20.56% |
| 2022 | 262.37 Million AUD | -10.84% |
| 2021 | 294.26 Million AUD | 33.03% |
| 2020 | 221.2 Million AUD | 295.02% |
| 2019 | 55.99 Million AUD | 4.63% |
| 2018 | 53.52 Million AUD | 10.89% |
| 2017 | 48.26 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 225.26 Million AUD | -28.79% |
| 2024 Q4 | 308.89 Million AUD | 460.98% |
| 2024 Q2 | 327.03 Million AUD | 45.18% |
| 2024 FY | 308.89 Million AUD | -2.35% |
| 2024 Q3 | 55.06 Million AUD | -83.16% |
| 2023 Q1 | 225.78 Million AUD | -13.95% |
| 2023 FY | 316.31 Million AUD | 20.56% |
| 2023 Q2 | 323.07 Million AUD | 43.09% |
| 2023 Q4 | 316.31 Million AUD | 46.97% |
| 2023 Q3 | 215.23 Million AUD | -33.38% |
| 2022 Q2 | 285.84 Million AUD | 44.16% |
| 2022 Q1 | 198.28 Million AUD | -32.62% |
| 2022 FY | 262.37 Million AUD | -10.84% |
| 2022 Q4 | 262.37 Million AUD | 56.54% |
| 2022 Q3 | 167.61 Million AUD | -41.36% |
| 2021 FY | 294.26 Million AUD | 33.03% |
| 2021 Q4 | 294.26 Million AUD | 25.83% |
| 2021 Q3 | 233.85 Million AUD | -36.25% |
| 2021 Q2 | 366.84 Million AUD | 84.44% |
| 2021 Q1 | 198.9 Million AUD | -10.08% |
| 2020 Q4 | 221.2 Million AUD | 40.21% |
| 2020 Q3 | 157.76 Million AUD | 0.0% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 FY | 221.2 Million AUD | 295.02% |
| 2019 FY | 55.99 Million AUD | 4.63% |
| 2018 FY | 53.52 Million AUD | 10.89% |
| 2017 FY | 48.26 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| BCAL Diagnostics Limited | 641.34 Thousand AUD | -48064.624% |
| Genetic Signatures Limited | 1.22 Million AUD | -25198.853% |
| Genetic Technologies Limited | 643.54 Thousand AUD | -47899.521% |
| Healius Limited | 1.59 Billion AUD | 80.668% |
| Imagion Biosystems Limited | 6.03 Million AUD | -5015.623% |
| Integral Diagnostics Limited | 357.79 Million AUD | 13.666% |
| INOVIQ Ltd | 535.05 Thousand AUD | -57631.764% |
| Microba Life Sciences Limited | 395.38 Thousand AUD | -78025.735% |
| Monash IVF Group Limited | 59.56 Million AUD | -418.591% |
| Rhythm Biosciences Limited | 163.82 Thousand AUD | -188457.703% |
| Sonic Healthcare Limited | 4.51 Billion AUD | 93.159% |